Sort
25,944 grants matching “neurodegeneration”
Role of T cells in tau-mediated neurodegeneration
$750,628David M Holtzman · Washington University · R01 · FY2024 · AG
Brain Bank Core
$750,617Ann Carolyn McKee · Boston University Medical Campus · U54 · FY2019 · NS
Mechanisms of gene-environment interaction in developmental lead exposure leading to Alzheimer's disease phenotypes
$750,493Jennifer L. Freeman · Purdue University · R01 · FY2023 · NS
Mechanisms of gene-environment interaction in developmental lead exposure leading to Alzheimer's disease phenotypes
$750,493Jennifer L. Freeman · Purdue University · R01 · FY2025 · NS
Mechanisms of gene-environment interaction in developmental lead exposure leading to Alzheimer's disease phenotypes
$750,493Jennifer L. Freeman · Purdue University · R01 · FY2024 · NS
Longitudinal MRI Investigation of Traumatic Microvascular Injury
$750,443Jeffrey B Ware · University Of Pennsylvania · R01 · FY2025 · NS
Understanding the chromatin remodeling factor kismet in glutamatergic neuron development and function
$750,399John Bethea · Drexel University · · FY2013 · BIO
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults
$750,331Giovanni Schifitto · University Of Rochester · R01 · FY2023 · AG
How do cells eliminate unassembled cytocolic proteins?
$750,247Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
The Epigenetics of Alzheimer's Disease
$750,001Li-Huei Tsai · Massachusetts Institute Of Technology · R01 · FY2015 · NS
The Epigenetics of Alzheimer's Disease
$750,000Li-Huei Tsai · Massachusetts Institute Of Technology · R01 · FY2012 · NS
The Epigenetics of Alzheimer's Disease
$750,000Li-Huei Tsai · Massachusetts Institute Of Technology · R01 · FY2011 · NS
Molecular Targets Modulating Neuro COVID Sequelae Linked to Tauopathy
$749,994Subhra Mohapatra · University Of South Florida · R01 · FY2024 · AG
Einstein Aging Study
$749,982Richard B. Lipton · Albert Einstein College Of Medicine, Inc · P01 · FY2016 · AG
Reserve against Disability in Early Multiple Sclerosis (RADIEMS) Longitudinal Cohort Study
$749,958James Francis Sumowski · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · HD
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
$749,922Don W. Cleveland · University Of California, San Diego · R01 · FY2025 · NS
Biological Aging Contributions to Molecular Pathology and Neurodegeneration
$749,867Corey T McMillan · University Of Pennsylvania · R01 · FY2021 · AG
Autophagon: an Autophagy-Functionalizing Gene Therapy Tool for Neurodegenerative Diseases
$749,845Abraam M. Yakoub · Brigham And Women'S Hospital · R01 · FY2025 · AG
Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia
$749,746Catherine L. Gallagher · University Of Wisconsin-Madison · R01 · FY2025 · AG
Role of KDM6B in Alzheimerâs disease related dementia
$749,508Yingfei Wang · Ut Southwestern Medical Center · R01 · FY2023 · AG
Role of KDM6B in Alzheimerâs disease related dementia
$749,508Yingfei Wang · Ut Southwestern Medical Center · R01 · FY2024 · AG
Repair Mechanisms For Oxidative DNA Damage
$749,397David M Wilson · Aging · Z01 · FY2007 · AG
Discovery of functionally selective Alzheimer's disease therapeutics
$749,313Robert R Luedtke · University Of North Texas Hlth Sci Ctr · R01 · FY2020 · AG
The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD
$749,200Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2019 · AG
Epigenomic analysis of neural circuits in Alzheimer's disease mouse models
$748,771Xiangmin Xu · University Of California-Irvine · R01 · FY2023 · AG